LUZ and Pfizer to Jointly Speak at 15th Annual eDM
Monique Rivas of LUZ and Katy Juliet Page, M.B.A. of Pfizer will Copresent at DIA Conference.
San Francisco, CA, November 19, 2014 --(PR.com)-- LUZ, Inc., a global provider of life science translation services, today announced that Monique Rivas, cofounder and chairman of LUZ and Katy Juliet Page, M.B.A., senior director submissions and operations support at Pfizer Ltd., United Kingdom will copresent at the DIA 15th Annual Conference on Electronic Document Management (eDM) in Berlin. The presentation entitled, “Harmonization and Standardization of Dossier Content, Information and Processes,” is part of the “Business Models to Get the Regulatory Work Done” session.
Ms. Rivas and Ms. Page will provide insight into the methodologies that were established to manage the translation of dossier content for over 70 locales/regions. Attendees will learn how Pfizer combined their world-class business process with LUZ’s AURORA translation management platform to create a centralized submissions process. The end result is process automation and, equally important, ecosystem transparency and cost savings through improved translation asset management.
“The dossier content project is a great example of how successful collaboration between our professional translation teams and our client at Pfizer led to millions of dollars in savings annually,” said Rivas. “I’m looking forward to sharing our strategy for global standardization and explaining the benefits of using our AURORA technology at the DIA eDM conference in December.”
Who: Monique Rivas of LUZ and Katy Juliet Page, M.B.A. of Pfizer
What: “Business Models to Get the Regulatory Work Done” session, “Harmonization and Standardization of Dossier Content, Information and Processes” presentation.
Where: Drug Information Association (DIA) 15th Annual Conference on Electronic Document Management (eDM) at the Maritim Hotel Berlin.
When: Wednesday, Dec. 03, 2014 from 8:30-10:00 a.m.
To find out more, or to inquire about meeting LUZ at the event, please contact us at http://www.luz.com/contact-us.
The Drug Information Association provides educational opportunities and facilitates communication among pharmaceutical and medical product development professionals.
About LUZ, Inc.
LUZ, Inc. was founded in 1994 on a straightforward business philosophy to provide high-quality translation services and solutions to life science companies worldwide. LUZ is certified as a women- and minority-owned business and maintains certifications to ISO 9001, ISO 13485, and EN 15038. Through its enterprise-level AURORA technology platform and regional offices, LUZ delivers peace of mind to corporate life science clients across the globe.
Ms. Rivas and Ms. Page will provide insight into the methodologies that were established to manage the translation of dossier content for over 70 locales/regions. Attendees will learn how Pfizer combined their world-class business process with LUZ’s AURORA translation management platform to create a centralized submissions process. The end result is process automation and, equally important, ecosystem transparency and cost savings through improved translation asset management.
“The dossier content project is a great example of how successful collaboration between our professional translation teams and our client at Pfizer led to millions of dollars in savings annually,” said Rivas. “I’m looking forward to sharing our strategy for global standardization and explaining the benefits of using our AURORA technology at the DIA eDM conference in December.”
Who: Monique Rivas of LUZ and Katy Juliet Page, M.B.A. of Pfizer
What: “Business Models to Get the Regulatory Work Done” session, “Harmonization and Standardization of Dossier Content, Information and Processes” presentation.
Where: Drug Information Association (DIA) 15th Annual Conference on Electronic Document Management (eDM) at the Maritim Hotel Berlin.
When: Wednesday, Dec. 03, 2014 from 8:30-10:00 a.m.
To find out more, or to inquire about meeting LUZ at the event, please contact us at http://www.luz.com/contact-us.
The Drug Information Association provides educational opportunities and facilitates communication among pharmaceutical and medical product development professionals.
About LUZ, Inc.
LUZ, Inc. was founded in 1994 on a straightforward business philosophy to provide high-quality translation services and solutions to life science companies worldwide. LUZ is certified as a women- and minority-owned business and maintains certifications to ISO 9001, ISO 13485, and EN 15038. Through its enterprise-level AURORA technology platform and regional offices, LUZ delivers peace of mind to corporate life science clients across the globe.
Contact
LUZ, Inc.
Diane DiPrima
415.981.5890 ext. 136
www.luz.com
Diane DiPrima
415.981.5890 ext. 136
www.luz.com
Contact
Categories